These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3596938)

  • 1. Single injection of three different preparations of alpha-interferon modifies morphine abstinence signs for a prolonged period.
    Dafny N; Reyes-Vazquez C
    Int J Neurosci; 1987 Feb; 32(3-4):953-61. PubMed ID: 3596938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine alters opiate withdrawal in rodents.
    Dafny N; Wagle VG; Drath DB
    Life Sci; 1985 May; 36(18):1721-6. PubMed ID: 4039025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats.
    Dafny N; Reyes-Vazquez C
    Immunopharmacology; 1985 Feb; 9(1):13-7. PubMed ID: 4039302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation-altered opiate withdrawal.
    Dafny N; Pellis NR
    Neuropharmacology; 1986 Aug; 25(8):815-8. PubMed ID: 3774111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon as an endocoids candidate preventing and attenuating opiate addiction.
    Dafny N
    Prog Clin Biol Res; 1985; 192():269-76. PubMed ID: 4080713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide and cortisol reduce the severity of morphine withdrawal.
    Montgomery SP; Dafny N
    Int J Immunopharmacol; 1987; 9(4):453-7. PubMed ID: 3623770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of morphine withdrawal to naloxone by interferon.
    Dafny N; Zielinksi M; Reyes-Vazquez C
    Neuropeptides; 1983 Oct; 3(6):453-63. PubMed ID: 6420721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of neuro-immunologic interactions: cyclosporine modifies opiate withdrawal by effects on the brain and immune components.
    Dougherty PM; Aronowski J; Drath D; Dafny N
    J Neuroimmunol; 1987 Jan; 13(3):331-42. PubMed ID: 3793881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine and alpha-interferon do not attenuate morphine withdrawal in rats but do impair thermoregulation.
    Dantzer R; Satinoff E; Kelley KW
    Physiol Behav; 1987; 39(5):593-8. PubMed ID: 3588704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon modifies morphine withdrawal phenomena in rodents.
    Dafny N
    Neuropharmacology; 1983 May; 22(5):647-51. PubMed ID: 6192350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modification of morphine and methadone dependence by interferon alpha.
    Dougherty PM; Pearl J; Krajewski KJ; Pellis NR; Dafny N
    Neuropharmacology; 1987 Nov; 26(11):1595-600. PubMed ID: 3431662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.
    Gold LH; Stinus L; Inturrisi CE; Koob GF
    Eur J Pharmacol; 1994 Feb; 253(1-2):45-51. PubMed ID: 8013548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats.
    Koyuncuoğlu H; Güngör M; Sağduyu H; Aricioğlu F
    Pharmacol Biochem Behav; 1990 Apr; 35(4):829-32. PubMed ID: 2345761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
    Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
    Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on seasonal variation in the development of morphine dependence in rats.
    Salem A; Hope W
    J Pharmacol Toxicol Methods; 1998 Oct; 40(3):151-7. PubMed ID: 10334631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
    Schulteis G; Heyser CJ; Koob GF
    Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of lymphoid cells in the withdrawal syndrome of opiate dependent rats.
    Pellis NR; Kletzly NE; Dougherty PM; Aronowski J; Dafny N
    Life Sci; 1987 Apr; 40(16):1589-93. PubMed ID: 3550348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.
    Marshall DC; Buccafusco JJ
    Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.